Elevated fasting blood glucose at admission is associated with poor outcomes in patients with COVID-19
Diabetes Metab
.
2021 Mar;47(2):101189.
doi: 10.1016/j.diabet.2020.08.004.
Epub 2020 Sep 4.
Authors
Shuyi Liu
1
,
Bin Zhang
1
,
Jingjing You
1
,
Luyan Chen
1
,
Huanchu Yuan
2
,
Shuixing Zhang
3
Affiliations
1
The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China.
2
Dongguan People's Hospital, Dongguan, Guangdong, China. Electronic address: 13686178013@139.com.
3
The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China. Electronic address: shui7515@126.com.
PMID:
32896652
PMCID:
PMC7472974
DOI:
10.1016/j.diabet.2020.08.004
No abstract available
Publication types
Letter
Comment
MeSH terms
Blood Glucose
COVID-19*
Diabetes Mellitus*
Fasting
Humans
SARS-CoV-2
Substances
Blood Glucose